503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-4.13%
Revenue decline while CRWD shows 5.94% growth. Joel Greenblatt would examine competitive position erosion.
-11.13%
Cost reduction while CRWD shows 7.31% growth. Joel Greenblatt would examine competitive advantage.
-3.01%
Gross profit decline while CRWD shows 5.45% growth. Joel Greenblatt would examine competitive position.
1.18%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
-10.41%
R&D reduction while CRWD shows 3.75% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.91%
Operating expenses reduction while CRWD shows 3.48% growth. Joel Greenblatt would examine advantage.
-20.59%
Total costs reduction while CRWD shows 4.38% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-17.02%
Both companies reducing D&A. Martin Whitman would check industry patterns.
35.36%
EBITDA growth while CRWD declines. John Neff would investigate advantages.
64.92%
EBITDA margin growth while CRWD declines. John Neff would investigate advantages.
35.36%
Operating income growth exceeding 1.5x CRWD's 9.37%. David Dodd would verify competitive advantages.
41.20%
Operating margin growth exceeding 1.5x CRWD's 14.45%. David Dodd would verify competitive advantages.
-41.97%
Other expenses reduction while CRWD shows 18.80% growth. Joel Greenblatt would examine advantage.
17.90%
Similar pre-tax income growth to CRWD's 20.26%. Walter Schloss would investigate industry trends.
22.98%
Similar pre-tax margin growth to CRWD's 24.73%. Walter Schloss would investigate industry trends.
776.40%
Tax expense growth while CRWD reduces burden. John Neff would investigate differences.
-15.11%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-11.45%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
-14.71%
EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-14.71%
Diluted EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-0.49%
Share count reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.
-0.46%
Diluted share reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.